What is new in chronic obstructive pulmonary disease?

J.L. Wright, H.A.M. Kerstjens, W. Timens

Source: Eur Respir Mon; 2007: 39: 153–169
Journal Issue: Pathology of the Lung
Disease area: Airway diseases

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J.L. Wright, H.A.M. Kerstjens, W. Timens. What is new in chronic obstructive pulmonary disease?. Eur Respir Mon; 2007: 39: 153–169

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Alveolar remodelling in COPD
Source: Annual Congress 2006 - PG15 - Remodelling and repair in lung disease
Year: 2006


Pathology of chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=159
Year: 2006

Systemic vascular function in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013

Disease of the airways in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: 41S-49S
Year: 2001



Clinical relevance of airway remodelling in airway diseases
Source: Eur Respir J 2007; 30: 134-155
Year: 2007



Definition and differential diagnosis of chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=1
Year: 2006

Local and systemic inflammation in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013


Systemic effects of chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 347-360
Year: 2003



Inflammatory cell microlocalisation and airway dysfunction: cause and effect?
Source: Eur Respir J 2007; 30: 1043-1056
Year: 2007



Exacerbations of chronic obstructive pulmonary disease: when are bacteria important?
Source: Eur Respir J 2002; 20: 9S-19S
Year: 2002



Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007


Emphysema contribution to the progression of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 654s
Year: 2006

Inflammation in COPD: a link to systemic comorbidities
Source: Eur Respir Rev 2007; 16: 91-97
Year: 2007



Interleukin-18 production and pulmonary function in COPD
Source: Eur Respir J 2008; 31: 287-297
Year: 2008



Chronic obstructive pulmonary disease and cardiac remodeling: gender aspect.
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018



Tools used to measure airway remodelling in research
Source: Eur Respir J 2007; 29: 596-604
Year: 2007



Multiple inflammatory hits and the pathogenesis of severe airway disease
Source: Eur Respir J 2006; 27: 884-888
Year: 2006



Pattern of airway inflammation and remodeling in mild chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010

Large airways remodeling in chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2008 - Pathophysiology of respiratory diseases
Year: 2008


Age-dependent systemic elastin degradation is enhanced in chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016